BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6311895)

  • 1. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.
    Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Bartalini M; Barbarulli G; Censini S; Soldateschi D; Tagliabue A
    J Immunol; 1983 Oct; 131(4):1707-13. PubMed ID: 6311895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity.
    Boraschi D; Ghezzi P; Pasqualetto E; Salmona M; Nencioni L; Soldateschi D; Villa L; Tagliabue A
    Immunology; 1983 Nov; 50(3):359-68. PubMed ID: 6354920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
    Boraschi D; Soldateschi D; Tagliabue A
    Eur J Immunol; 1982 Apr; 12(4):320-6. PubMed ID: 6178603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of macrophage suppression and cytotoxicity by interferon role of Ia-bearing macrophages.
    Boraschi D; Niederhuber JE
    J Immunol; 1982 Nov; 129(5):1854-8. PubMed ID: 6956630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage antitumor activity: impaired responsiveness to interferon-gamma of macrophages from genetically defective mice.
    Boraschi D; Censini S; Tagliabue A
    Eur J Immunol; 1984 Nov; 14(11):1061-3. PubMed ID: 6437846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-beta-induced reduction of superoxide anion generation by macrophages.
    Boraschi D; Ghezzi P; Salmona M; Tagliabue A
    Immunology; 1982 Apr; 45(4):621-8. PubMed ID: 6175565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production.
    Boraschi D; Censini S; Tagliabue A
    J Immunol; 1984 Aug; 133(2):764-8. PubMed ID: 6330202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of macrophage suppressive activity and prostaglandin release by lymphokines and interferon: comparison of alveolar, pleural and peritoneal macrophages.
    Sestini P; Tagliabue A; Boraschi D
    Clin Exp Immunol; 1984 Dec; 58(3):573-80. PubMed ID: 6509795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
    Ohyama K
    Nihon Geka Hokan; 1993 Mar; 62(2):92-115. PubMed ID: 8239865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
    Hamann U; Krammer PH
    Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
    James SL; Skamene E; Meltzer MS
    J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of L-arginine on the retention of macrophage tumoricidal activity.
    Takema M; Inaba K; Uno K; Kakihara K; Tawara K; Muramatsu S
    J Immunol; 1991 Mar; 146(6):1928-33. PubMed ID: 2005387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
    Ohyama K; Kikuchi H; Oda Y; Moritake K; Yamasaki T
    No To Shinkei; 1993 Jun; 45(6):525-30. PubMed ID: 8363848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
    Taramelli D; Holden HT; Varesio L
    J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma.
    Blasi E; Herberman RB; Varesio L
    J Immunol; 1984 Jun; 132(6):3226-8. PubMed ID: 6725951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
    Schafer R; Nacy CA; Eisenstein TK
    J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus-induced suppression of macrophage-mediated tumoricidal activity in murine macrophages.
    Koff WC; Dunegan MA; Chakrabarty MK; Hampar B; Showalter SD
    Cancer Res; 1987 Mar; 47(6):1534-7. PubMed ID: 2434219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.